March 07, 2025CorporateUltimaster Nagomi™ and Ultimaster™ Tansei™ are now MDR certified for patients at high bleeding risk
February 27, 2025CorporateTerumo and Daiichi Sankyo partner to support cardiovascular care in Vietnam
February 25, 2025CorporateNational Alliance of Sickle Cell Centers and Terumo Blood and Cell Technologies Working Together to Improve Outcomes for Patients with Sickle Cell DiseaseThe BET on Blood for SCD collaboration aims to improve the lives of Sickle Cell Warriors by connecting healthcare providers with education about proven treatments to help manage the disease
March 07, 2025CorporateUltimaster Nagomi™ and Ultimaster™ Tansei™ are now MDR certified for patients at high bleeding risk
February 27, 2025CorporateTerumo and Daiichi Sankyo partner to support cardiovascular care in Vietnam
February 25, 2025CorporateNational Alliance of Sickle Cell Centers and Terumo Blood and Cell Technologies Working Together to Improve Outcomes for Patients with Sickle Cell DiseaseThe BET on Blood for SCD collaboration aims to improve the lives of Sickle Cell Warriors by connecting healthcare providers with education about proven treatments to help manage the disease
Investors Japanese Financial Results for the Third Quarter of the Fiscal Year Ending 3/2025 Feb. 13, 2025 IR Library Audio Webcast Stock Quote Prime Market of TSE: 4543 Last Trade 2,809.0 JPY Change -2.0 JPY (-0.07%) Volume 3,203,100 3:30 PM Mar 26, 2025 View Chart Top Management Message Hikaru Samejima Chief Executive Officer GS26: 5-Year Growth strategy 2022 - 2026 IR Library IR materials and various reports Terumo Report Integrated Report 2024 Sustainability Sustainability at the Terumo Group From Devices to Solutions Vision for the Next 10 Years Shareholders & Stock Information on shareholders meeting and stock What's New February 14, 2025 Audio webcast and Q&A regarding Financial Results for the Third Quarter of FYE 3/2025 February 13, 2025 Presentation regarding Financial Results for the Third Quarter of FYE 3/2025 December 03, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan) November 08, 2024 Audio webcast and Q&A regarding Financial Results for the Second Quarter of FYE 3/2025 November 07, 2024 Presentation regarding Financial Results for the Second Quarter of FYE 3/2025 View all Business Overview Introduction to the businesses operated by the Terumo Group /business Technology Introduction to Terumo's research and development activities and production system /technology
February 14, 2025 Audio webcast and Q&A regarding Financial Results for the Third Quarter of FYE 3/2025
December 03, 2024 Notice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
November 08, 2024 Audio webcast and Q&A regarding Financial Results for the Second Quarter of FYE 3/2025
